Hexa Reports Industry Chronic Obstructive Pulmonary Disease Market | Page 2

Scope  The Chronic obstructive pulmonary disease (COPD) EpiCast Report provides an overview of the risk factors and global trends of COPD in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and Australia). It includes a 10-year epidemiological forecast for the total prevalent cases of COPD (diagnosed and undiagnosed cases) and the diagnosed prevalent cases of COPD, which are segmented by sex and age (35-44, 45-54, 55-64, 65-74, and 75 years and older). The diagnosed prevalent cases of COPD are further segmented by the new GOLD 2011 severity stage (GOLD A, GOLD B, GOLD C, and GOLD D) using the COPD Assessment Test (CAT) scores and the modified Medical Research Council (mMRC) dyspnea scores.  The COPD epidemiology report is written and developed by Mastersand PhD-level epidemiologists.  The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM. Request A Sample copy of This Report @ http://www.hexareports.com/report/epicast-report- chronic-obstructive-pulmonary-disease-epidemiology-forecasts-to-2025/request-sample Reasons To Buy 1. Develop business strategies by understanding the trends shaping and driving the global COPD market. 2. Quantify patient populations in the global COPD market to improve product design, pricing, and launch plans. 3. Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for COPD therapeutics in each of the markets covered. 4. Understand severity stages of COPD cases by CAT score and mMRC scores. Browse More Pharmaceuticals & Healthcare Related Market Research Reports: • EpiCast Report: Hemophilia - Epidemiology Forecast to 2026 - http://www.hexareports.com/report/epicast-report-hemophilia-epidemiology-forecast-to-2026 • EpiCast Report: Heart Failure - Epidemiology Forecasts to 2026 - http://www.hexareports.com/report/epicast-report-heart-failure-epidemiology-forecasts-to-2026 • Chlamydia Infections Global Clinical Trials Review, H1, 2017 - http://www.hexareports.com/report/chlamydia-infections-global-clinical-trials-review-h1-2017 Follow Us: